Monitoring glioblastoma extracellular vesicle evolution using a nanodiagnostic platform to detect glioma stem cells driving recurrent disease
Science Advances · 2026
DOI: 10.1126/sciadv.adt2804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Zhen Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD 4072, Australia. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Extracellular Vesicles, Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Australian Research Council, National Health and Medical Research Council, China Scholarship Council.
Abstract (Originalsprache)
Assessing therapeutic response in glioblastoma (GBM) is a major factor limiting the clinical development of effective therapies. The intracranial location limits serial biopsies and only provides an intermittent view of the tumor molecular profile from the initial resection. Liquid biopsy techniques, specifically small extracellular vesicle (sEV) analysis, have the potential to overcome these limitations by providing a window into the brain using peripheral blood. To address the need for monitoring tumor evolution and therapeutic resistance, we developed a GBM biomarker panel (ATPase subunit beta-2, excitatory amino acid transporter 2, CD24, CD44, CD133, and epidermal growth factor receptor) for multiplexed profiling of sEVs using an advanced GBM Extracellular Vesicle Monitoring Phenotypic Analyzer Chip. We successfully tracked patient response to treatment by monitoring changes in glioma stem cell markers on circulating sEVs. We propose that these results provide a strong rationale for using GBM sEVs as a serial monitoring tool in the future clinical management of patients with GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD 4072, Australia.
- School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, NSW 2308, Australia.
- Mark Hughes Foundation Centre for Brain Cancer Research, University of Newcastle, Newcastle, NSW 2308, Australia.
- Hunter Medical Research Institute, New Lambton Heights, Newcastle, NSW 2305, Australia.
- Key Laboratory of OptoElectronic Science and Technology for Medicine, Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou 350007, China.
- Cancer Research Department, QIMR Berghofer Medical Research Institute, Sid Faithfull Brain Cancer Laboratory, Brisbane, QLD 4006, Australia.
ORCID-Profile: Zhen Zhang, Richard J Lobb, Paul Tooney, Jing Wang, Rebecca Lane, Quan Zhou, Xueming Niu, Sam Faulkner, Bryan W Day, Matt Trau
Förderung
- Australian Research Council
- National Health and Medical Research Council
- China Scholarship Council
- Mark Hughes Foundation
Zitieren
APA
Zhang, Z., Lobb, R. J., Tooney, P., Wang, J., Lane, R., Zhou, Q., Niu, X., Faulkner, S., Al-Iedani, O., Day, B. W., Puttick, S., Rose, S., Fay, M., & Trau, M. (2026). Monitoring glioblastoma extracellular vesicle evolution using a nanodiagnostic platform to detect glioma stem cells driving recurrent disease. Science Advances. https://doi.org/10.1126/sciadv.adt2804
Vancouver
Zhang Z, Lobb RJ, Tooney P, Wang J, Lane R, Zhou Q, et al. Monitoring glioblastoma extracellular vesicle evolution using a nanodiagnostic platform to detect glioma stem cells driving recurrent disease. Science Advances. 2026. doi:10.1126/sciadv.adt2804
BibTeX
@article{Zhang2026,
author = {Zhang, Zhen and Lobb, Richard J and Tooney, Paul and Wang, Jing and Lane, Rebecca and Zhou, Quan and Niu, Xueming and Faulkner, Sam and Al-Iedani, Oun and Day, Bryan W and Puttick, Simon and Rose, Stephen and Fay, Mike and Trau, Matt},
title = {Monitoring glioblastoma extracellular vesicle evolution using a nanodiagnostic platform to detect glioma stem cells driving recurrent disease},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.adt2804}
}
EUVIMED